Epigenetic Regulation of MicroRNA Expression by Hepatitis B Virus Pre‐S2 Mutant Promotes Hepatocellular Carcinoma Tumorigenesis
Liver International · 2026-04 · 46 (4)
DOI: 10.1111/liv.70582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 08.03.2026. Verfasst von Yueh-Te Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Genome Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Hepatocellular, Liver Neoplasms, Epigenesis, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: China Medical University, Taiwan, National Science and Technology Council, Chang Gung Memorial Hospital.
Abstract (Originalsprache)
Background & Aims Discovery of therapeutic targets for hepatocellular carcinoma (HCC) is urgently needed. As an important hepatitis B virus (HBV) oncoprotein, pre‐S2 mutant activates multiple signalling pathways to induce HCC development.
Methods
This study investigated the effect of pre‐S2 mutant on regulating microRNA (miRNA) expression and the role of miRNAs in mediating pre‐S2 mutant's oncogenic functions.
Results
The results showed that 9 miRNAs were downregulated in both tumour tissues of pre‐S2 mutant‐positive HCC patients and pre‐S2 mutant‐expressed human HCC cell lines, contributing to pre‐S2 mutant‐promoted cell proliferation, anchorage‐independent cell growth, cell cycle progression, and tumour growth and malignancy. Moreover, pre‐S2 mutant downregulated miRNA expression at the epigenetic levels through suppression of lysine acetyltransferase 3B (KAT3B)‐ and KAT5‐mediated histone H3 lysine 9 acetylation (H3K9ac) and H4K5ac modifications. The decreased levels of pre‐S2 mutant‐dysregulated miRNAs could also be detected in blood exosomes of patients.
Conclusions
Collectively, this study provided new mechanistic insights and therapeutic perspectives for pre‐S2 mutant‐associated HCC tumorigenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Genome Research Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
- Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.
- Department of Surgery, China Medical University Hospital, Taichung, Taiwan.
- Cell Therapy Center, China Medical University Hospital, Taichung, Taiwan.
- School of Medicine, China Medical University, Taichung, Taiwan.
- Ph.D. Program for Biotech Pharmaceutical Industry, China Medical University, Taichung, Taiwan.
ORCID-Profile: Chiao-Fang Teng
Förderung
- China Medical University, Taiwan
- National Science and Technology Council
- Chang Gung Memorial Hospital
Zitieren
APA
Lin, Y. T., Jeng, L. B., Shih, F. Y., & Teng, C. F. (2026). Epigenetic Regulation of MicroRNA Expression by Hepatitis B Virus Pre‐S2 Mutant Promotes Hepatocellular Carcinoma Tumorigenesis. Liver International, 46(4). https://doi.org/10.1111/liv.70582
Vancouver
Lin YT, Jeng LB, Shih FY, Teng CF. Epigenetic Regulation of MicroRNA Expression by Hepatitis B Virus Pre‐S2 Mutant Promotes Hepatocellular Carcinoma Tumorigenesis. Liver International. 2026;46(4). doi:10.1111/liv.70582
BibTeX
@article{Lin2026,
author = {Lin, Yueh-Te and Jeng, Long-Bin and Shih, Fu-Ying and Teng, Chiao-Fang},
title = {Epigenetic Regulation of MicroRNA Expression by Hepatitis B Virus Pre‐S2 Mutant Promotes Hepatocellular Carcinoma Tumorigenesis},
journal = {Liver International},
year = {2026},
volume = {46},
number = {4},
doi = {10.1111/liv.70582}
}
EUVIMED